Page last updated: 2024-09-03

astragaloside a and alpha-synuclein

astragaloside a has been researched along with alpha-synuclein in 1 studies

Compound Research Comparison

Studies (astragaloside a)	Trials (astragaloside a)	Recent Studies (post-2010) (astragaloside a)	Studies (alpha-synuclein)	Trials (alpha-synuclein)	Recent Studies (post-2010) (alpha-synuclein)
675	5	573	10,821	29	8,011

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, X; Qiu, J; Wang, S; Yu, C; Zhang, J	1

Other Studies

1 other study(ies) available for astragaloside a and alpha-synuclein

Article	Year
Astragaloside IV attenuates the H2O2-induced apoptosis of neuronal cells by inhibiting α-synuclein expression via the p38 MAPK pathway. International journal of molecular medicine, 2017, Volume: 40, Issue:6 Topics: alpha-Synuclein; Antioxidants; Apoptosis; Cell Line; Humans; Hydrogen Peroxide; Neurons; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Saponins; Triterpenes	2017

Article

Year

Astragaloside IV attenuates the H2O2-induced apoptosis of neuronal cells by inhibiting α-synuclein expression via the p38 MAPK pathway.

International journal of molecular medicine, 2017, Volume: 40, Issue:6

Topics: alpha-Synuclein; Antioxidants; Apoptosis; Cell Line; Humans; Hydrogen Peroxide; Neurons; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Saponins; Triterpenes

2017